Research Options:

Week of Expected Pricing Withdrawn
Company Name KLOX TECHNOLOGIES, INC.
Proposed Ticker KLOX
CUSIP 49876X105
Business Description A specialty pharmaceutical company focused on developing and commercializing products based on our proprietary BioPhotonic technology platform to address skin and soft tissue disorders.
Lead Underwriter UBS Investment Bank
Co-Managers Canaccord Genuity Inc, National Bank of Canada Financial Inc, Needham & Company, LLC
Initial Shares 4,800,000
Revised Initial Shares N/A
Initial Price $13.00-$15.00
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 

   
  © 2024 ICE Data Services. All rights reserved.